Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fabre invests in French manufacturing

This article was originally published in Scrip

Executive Summary

Pierre Fabreplans to invest €70 million to expand its manufacturing capacity at its Soual site, near Castres in the Tarn region of France. The investment involves an additional 15,000m2 facility capable of producing an additional 60 million units of dermatology and cosmetic products destined mainly for overseas markets. Work is expected to begin a year from now and the facility is expected to become operational in 2011. The investment will add around 150 new employees to the company's workforce of 10,000.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC031416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel